Document is current
Any future updates will be listed below
-
Authors
Rehell, Minna
Le Bourlout, Yohann https://orcid.org/0000-0002-8296-334X
Kelppe, Jetta
Rautava, Jaana
Perra, Emanuele
Rantanen, Jouni
Ehnholm, Gösta
Hayward, Nick
Nyman, Kristofer
Pritzker, Kenneth P. H.
Tarkkanen, Jussi
Atula, Timo
Nieminen, Heikki J. https://orcid.org/0000-0001-6084-1272
Aro, Katri L S
-
Funding
Funding for this research was provided by:
Business Finland (5607/31/2018, 5607/31/2018)
Academy of Finland (314286, 335799, 314286)
- License Information
-
More Information
Article History
Received: 11 September 2024
Accepted: 2 March 2025
First Online: 26 March 2025
Declarations
:
: H.J.N., K.P.H.P. and Y.L.B have stock ownership in Swan Cytologics Inc., Toronto, ON, Canada. H.J.N. and K.P.H.P. are inventors within the patent family associated with WO2018000102A1. Y.L.B., G.E. and H.J.N. are inventors within the patent family associated with WO2020240084A1. Y.L.B, G.E. and J.R. are inventors within the patent family associated with EP4101402A. The remaining authors have no competing interests to declare.
: This study protocol was reviewed and approved by the Helsinki University Hospital Research Ethics Committee, approval number (HUS/241/2021). All participating patients provided signed informed consent.
